CALR mutations are restricted to MPN subtypes displaying aberrant megakaryopoiesis, such as ET, PMF, and post essential thrombocythemia-myelofibrosis (post-ET-MF) [3]. The gene discussed is CALR; the disease is myeloproliferative neoplasm.